Skip to content

Dr. Julie BOLLEN

Active
Private limited companyfounded 2023active for 3 yearsBordeauxstraat 7, 2000 Antwerpen, BelgiumKBO/BCE: BE 1000.705.943
Summary

Dr. Julie BOLLEN has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €124,050 and a net result of €64,440. Its solvency ranks better than 65% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 03-10-2023 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.351.125.392 2000 Antwerpen, since 03-10-2023
Financial year end
31 December
Peppol
Reachable since 27-03-2026

Board and ownership

Board
  • Bollen JulieDirector

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€81,901
▲ 12.8%
Turnover
≈ €180,000
estimated
Profit
€64,440
▲ 12.8%
Equity
€124,050
▲ 108%
Total assets
€163,318
▲ 115%
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.57, cash €127,401Equity €124,050 (76.0% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 83% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 76.0% of total assets
Liquidity 93=
short-term debt 21.8% · cash 78.0%
Profitability 100=
return on assets 39.5%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 0.3% 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.4%▲ +0.1 percentage points vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025highest value 07-2025: < 0.1%▼ -0.4 percentage points vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €12,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 4.57 (4.54 in 2024), above the usual 1.5. Short-term debt is 21.8% and cash 78% of total assets. 24% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 78% on liquidity, 80% on profitability and 90% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.57, cash €127,401
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Equity €124,050 (76.0% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
32 days early
2024
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 32 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Key points

  • Positive: Equity rose in 2025from €59,609 to €124,050 ▲ 108% View

Recent changes

  1. · Gazette deed Registered office moved within Antwerpen
  2. · Gazette deed Incorporation
All 5 events

Comparable companies

These companies have the same main activity as Dr. Julie BOLLEN: general medical practice (NACE 86210). They are comparable in size and age: total assets between €147,000 and €176,000, founded in 2023.

CompanyTotal assetsGross margin
Dr. Julie BOLLEN Antwerpen€163,318€81,901
Dr. Julie Lecomte Brecht€160,447€77,703
Dr. Anthonissen Jasmien Brecht€165,773€80,270
Dr. Catya Franssen Wuustwezel€146,758€81,569
CHRISTINE VAN HAEGENBORGH Kontich€157,524€91,331
Dokter Buytaert Kobe Bornem€176,256€91,347
DR. ELISE GOETSCHALCKX Rijkevorsel€172,608€92,150
Full comparison

Key facts about Dr. Julie BOLLEN

What is the company number of Dr. Julie BOLLEN?
The company number of Dr. Julie BOLLEN is 1000.705.943. The VAT number is the same number with BE in front: BE 1000.705.943.
Where is Dr. Julie BOLLEN based?
The registered office is at Bordeauxstraat 7, 2000 Antwerpen.Company details
What does Dr. Julie BOLLEN do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Julie BOLLEN?
The legal form of Dr. Julie BOLLEN is Private limited company (BV).
When was Dr. Julie BOLLEN founded?
Dr. Julie BOLLEN was founded on 03-10-2023.
Is Dr. Julie BOLLEN still active?
Yes, Dr. Julie BOLLEN is an active enterprise in the KBO register.
What is the turnover of Dr. Julie BOLLEN?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €81,901 and 32 comparable companies (NACE 862). It probably lies between €140,000 and €240,000.Financials
Is Dr. Julie BOLLEN profitable?
In financial year 2025, Dr. Julie BOLLEN made a profit of €64,440.
Where can I find the annual accounts of Dr. Julie BOLLEN?
Dr. Julie BOLLEN filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Julie BOLLEN due?
Dr. Julie BOLLEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.